These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Percutaneous radiofrequency ablation in intrahepatic cholangiocarcinoma: a retrospective single-center experience. Brandi G; Rizzo A; Dall'Olio FG; Felicani C; Ercolani G; Cescon M; Frega G; Tavolari S; Palloni A; De Lorenzo S; Abbati F; Mollica V; Ricci AD; Serra C Int J Hyperthermia; 2020; 37(1):479-485. PubMed ID: 32396398 [No Abstract] [Full Text] [Related]
43. Percutaneous radiofrequency ablation for small hepatocellular carcinoma in hepatic dome under MR-guidance: clinical safety and efficacy. Chen J; Lin Z; Lin Q; Lin R; Yan Y; Chen J Int J Hyperthermia; 2020; 37(1):192-201. PubMed ID: 32066293 [No Abstract] [Full Text] [Related]
45. Radiofrequency ablation versus resection for technically resectable colorectal liver metastasis: a propensity score analysis. Wang LJ; Zhang ZY; Yan XL; Yang W; Yan K; Xing BC World J Surg Oncol; 2018 Oct; 16(1):207. PubMed ID: 30322402 [TBL] [Abstract][Full Text] [Related]
46. Efficacy of transarterial chemoembolization compared with radiofrequency ablation for the treatment of recurrent hepatocellular carcinoma after radiofrequency ablation. Wang X; Liang H; Lu Z Minim Invasive Ther Allied Technol; 2020 Dec; 29(6):344-352. PubMed ID: 31375044 [No Abstract] [Full Text] [Related]
47. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome. Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723 [TBL] [Abstract][Full Text] [Related]
48. No-touch multibipolar radiofrequency ablation vs. surgical resection for solitary hepatocellular carcinoma ranging from 2 to 5 cm. Mohkam K; Dumont PN; Manichon AF; Jouvet JC; Boussel L; Merle P; Ducerf C; Lesurtel M; Rode A; Mabrut JY J Hepatol; 2018 Jun; 68(6):1172-1180. PubMed ID: 29410287 [TBL] [Abstract][Full Text] [Related]
49. The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC. Bai XM; Cui M; Yang W; Wang H; Wang S; Zhang ZY; Wu W; Chen MH; Yan K; Goldberg SN Radiology; 2021 Aug; 300(2):458-469. PubMed ID: 34003058 [TBL] [Abstract][Full Text] [Related]
50. Radiofrequency ablation of recurrent cholangiocarcinoma. Slakey DP Am Surg; 2002 Apr; 68(4):395-7. PubMed ID: 11952256 [TBL] [Abstract][Full Text] [Related]
51. Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma. Weis S; Franke A; Mössner J; Jakobsen JC; Schoppmeyer K Cochrane Database Syst Rev; 2013 Dec; (12):CD003046. PubMed ID: 24357457 [TBL] [Abstract][Full Text] [Related]
52. Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up. Forauer AR; Dewey BJ; Seigne JD Urol Oncol; 2014 Aug; 32(6):869-76. PubMed ID: 24946958 [TBL] [Abstract][Full Text] [Related]
53. [The comparative results of radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma]. Cho CM; Tak WY; Kweon YO; Kim SK; Choi YH; Hwang YJ; Kim YI Korean J Hepatol; 2005 Mar; 11(1):59-71. PubMed ID: 15788886 [TBL] [Abstract][Full Text] [Related]
54. Percutaneous CT-guided radiofrequency ablation for unresectable hepatocellular carcinoma pulmonary metastases. Li X; Wang J; Li W; Huang Z; Fan W; Chen Y; Shen L; Pan T; Wu P; Zhao M Int J Hyperthermia; 2012; 28(8):721-8. PubMed ID: 23153217 [TBL] [Abstract][Full Text] [Related]
55. Successful local treatment for repeated hepatic recurrences of cholangiolocellular carcinoma: a report on a long-term survivor. Shinohara K; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Yamaguchi J; Shimoyama Y; Shiina S; Tateishi R; Arano T; Nagino M Surg Case Rep; 2017 Dec; 3(1):120. PubMed ID: 29198012 [TBL] [Abstract][Full Text] [Related]
56. [Randomized clinical trial of percutaneous radiofrequency ablation plus absolute ethanol injection compared with radiofrequency ablation alone for small hepatocellular carcinoma]. Chen MS; Zhang YJ; Li JQ; Liang HH; Zhang YQ; Zheng Y Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):623-5. PubMed ID: 16438875 [TBL] [Abstract][Full Text] [Related]
57. Combined radiofrequency ablation and ethanol injection versus repeat hepatectomy for elderly patients with recurrent hepatocellular carcinoma after initial hepatic surgery. Chen S; Peng Z; Xiao H; Lin M; Chen Z; Jiang C; Hu W; Xie X; Liu L; Peng B; Kuang M Int J Hyperthermia; 2018 Nov; 34(7):1029-1037. PubMed ID: 28974113 [TBL] [Abstract][Full Text] [Related]
59. Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy: therapeutic efficacy on early- and late-phase recurrence. Yang W; Chen MH; Yin SS; Yan K; Gao W; Wang YB; Huo L; Zhang XP; Xing BC AJR Am J Roentgenol; 2006 May; 186(5 Suppl):S275-83. PubMed ID: 16632688 [TBL] [Abstract][Full Text] [Related]
60. Radiofrequency ablation versus resection for the treatment of early stage hepatocellular carcinoma: a multicenter Australian study. Gory I; Fink M; Bell S; Gow P; Nicoll A; Knight V; Dev A; Rode A; Bailey M; Cheung W; Kemp W; Roberts SK; Scand J Gastroenterol; 2015 May; 50(5):567-76. PubMed ID: 25615260 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]